[
  {
    "ts": null,
    "headline": "Top Stock Reports for Wells Fargo, Abbott & American Express",
    "summary": "Wells Fargo gains post-Fed cap removal, Abbott rides strong devices pipeline, while AmEx sees growth but rising costs pinch margins.",
    "url": "https://finnhub.io/api/news?id=c2d069ba636b1eaf150ef0f514f84d7e6e1df711b4ea0cb71793ed93a5aaeb3b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753304760,
      "headline": "Top Stock Reports for Wells Fargo, Abbott & American Express",
      "id": 136062210,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Wells Fargo gains post-Fed cap removal, Abbott rides strong devices pipeline, while AmEx sees growth but rising costs pinch margins.",
      "url": "https://finnhub.io/api/news?id=c2d069ba636b1eaf150ef0f514f84d7e6e1df711b4ea0cb71793ed93a5aaeb3b"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer Says He “Was Discouraged to Get a Mixed Update from Abbott Labs”",
    "summary": "Abbott Laboratories (NYSE:ABT) is one of the stocks that Jim Cramer shed light on. Commenting on the company’s recent earnings report results, Cramer said: “Today, in an otherwise positive market, I was discouraged to get a mixed update from Abbott Labs, medical technology company that we’ve long owned for the Charitable Trust… I’d say two […]",
    "url": "https://finnhub.io/api/news?id=a1106acdeed95f825b12527c9dcab850002d205b541f8dfe7afcb8445654a966",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753282479,
      "headline": "Jim Cramer Says He “Was Discouraged to Get a Mixed Update from Abbott Labs”",
      "id": 136062241,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott Laboratories (NYSE:ABT) is one of the stocks that Jim Cramer shed light on. Commenting on the company’s recent earnings report results, Cramer said: “Today, in an otherwise positive market, I was discouraged to get a mixed update from Abbott Labs, medical technology company that we’ve long owned for the Charitable Trust… I’d say two […]",
      "url": "https://finnhub.io/api/news?id=a1106acdeed95f825b12527c9dcab850002d205b541f8dfe7afcb8445654a966"
    }
  },
  {
    "ts": null,
    "headline": "Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know",
    "summary": "Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
    "url": "https://finnhub.io/api/news?id=2fc680241544b1108242787c8c846a582b1d18d7577eedfb2c9fa6cfbdd91d70",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753275603,
      "headline": "Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know",
      "id": 136062242,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
      "url": "https://finnhub.io/api/news?id=2fc680241544b1108242787c8c846a582b1d18d7577eedfb2c9fa6cfbdd91d70"
    }
  },
  {
    "ts": null,
    "headline": "Institutional owners may ignore Abbott Laboratories' (NYSE:ABT) recent US$10b market cap decline as longer-term profits stay in the green",
    "summary": "Key Insights Institutions' substantial holdings in Abbott Laboratories implies that they have significant influence...",
    "url": "https://finnhub.io/api/news?id=b0cb2615349b33ed9eb1e1c04823142054763ae6bb7b0544308d9b8dc7853841",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753268414,
      "headline": "Institutional owners may ignore Abbott Laboratories' (NYSE:ABT) recent US$10b market cap decline as longer-term profits stay in the green",
      "id": 136044218,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Key Insights Institutions' substantial holdings in Abbott Laboratories implies that they have significant influence...",
      "url": "https://finnhub.io/api/news?id=b0cb2615349b33ed9eb1e1c04823142054763ae6bb7b0544308d9b8dc7853841"
    }
  },
  {
    "ts": null,
    "headline": "[Latest] Global Inferior Vena Cava IVC Filter Market Size/Share Worth USD 2,094.10 Million by 2034 at a 8.88% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT)",
    "summary": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Inferior Vena Cava IVC Filter Market size & share revenue was valued at approximately USD 895.82 Million in 2024 and is expected to reach USD 974.16 Million in 2025 and is expected to reach around USD 2,094.10 Million by 2034, at a CAGR of 8.88% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Abbott, B.",
    "url": "https://finnhub.io/api/news?id=aef0a10f3f44579c2de3768d1afc9546fddb66fcce8d37d782b537a1fddc9e35",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753259400,
      "headline": "[Latest] Global Inferior Vena Cava IVC Filter Market Size/Share Worth USD 2,094.10 Million by 2034 at a 8.88% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT)",
      "id": 136039638,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Inferior Vena Cava IVC Filter Market size & share revenue was valued at approximately USD 895.82 Million in 2024 and is expected to reach USD 974.16 Million in 2025 and is expected to reach around USD 2,094.10 Million by 2034, at a CAGR of 8.88% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Abbott, B.",
      "url": "https://finnhub.io/api/news?id=aef0a10f3f44579c2de3768d1afc9546fddb66fcce8d37d782b537a1fddc9e35"
    }
  }
]